Macquarie Group
DCPH

Macquarie Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Macquarie Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,862
Closed -$76K – 2183
2022
Q3 		$76K Sell
3,862
-261
-6% -$4.1K ﹤0.01% 1844
2022
Q2 		$54K Hold
4,123
– – ﹤0.01% 2030
2022
Q1 		$38 Hold
4,123
– – ﹤0.01% 2238
2021
Q4 		$40K Sell
4,123
-1,373
-25% -$25.8K ﹤0.01% 2230
2021
Q3 		$187K Buy
5,496
+3,491
+174% +$111K ﹤0.01% 1813
2021
Q2 		$73K Buy
2,005
+954
+91% +$36.9K ﹤0.01% 2068
2021
Q1 		$47K Sell
1,051
-322
-23% -$15K ﹤0.01% 2094
2020
Q4 		$78K Hold
1,373
– – ﹤0.01% 1928
2020
Q3 		$70K Hold
1,373
– – ﹤0.01% 1873
2020
Q2 		$82K Buy
+1,373
New +$73.4K ﹤0.01% 1811

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Macquarie Group's DCPH Position: Q4 2022 in Review

Macquarie Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2022, closing a stake of 3,862 shares — an estimated $76K sold.

Macquarie Group first reported a position in DCPH in Q2 2020 and held it in 10 quarters. The position peaked at $187K in Q3 2021. 143 funds tracked by Wall St. Rank hold DCPH as of Q4 2022.

  • Macquarie Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 3,862 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $76K.
  • Macquarie Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • Macquarie Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $187K in Q3 2021.
  • 143 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.